recent articles

practice updates

NAC for Prevention of Contrast-Induced Nephropathy

"In patients with CIN risk factors, there is currently insufficient evidence to recommend routine NAC use"
Thanks to Artur Pawlowicz, MD and Matthew Ryan, MD, Ph.D. for this overview of the literature on the role (or lack thereof) of n-acetylcysteine in preventing contrast-induced nephropathy.